Test Price
550 AED✅ Home Collection Available
Dengue Fever Antibodies IgG & IgM ICT Test in UAE | 550 AED | 2026 DHA Guidelines
تحليل الأجسام المضادة لحمى الضنك IgG وIgM في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي
Test Overview & Clinical Utility
The Dengue Fever Antibodies IgG & IgM ICT Test is a qualitative lateral-flow immunochromatographic assay designed for the rapid serological detection and differentiation of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies specific to the Dengue virus in human serum. This test is indicated for patients presenting with acute febrile illness in dengue-endemic regions, including the UAE during post-monsoon and travel-associated outbreak periods. يُستخدم هذا الفحص للتمييز بين العدوى الأولية الحادة (IgM إيجابي فقط) والعدوى الثانوية (IgG وIgM إيجابيان معاً) والتعرض السابق للفيروس (IgG إيجابي فقط).
| Feature | Our Test: ICT (This Panel) | ELISA (Alternative) | RT-PCR (Alternative) |
|---|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity; ISO-validated membrane-based detection | 94–97% Sensitivity; plate-based enzyme reaction | 98–99% Sensitivity; detects viral RNA (NS1/gene targets) |
| Methodology | Immunochromatographic Test (ICT) – Lateral Flow | Enzyme-Linked Immunosorbent Assay | Reverse Transcription Polymerase Chain Reaction |
| Turnaround Time | Same Day (Daily Processing) | 24–48 Hours | 4–6 Hours (Limited Availability) |
| Clinical Window | Day 3–5 Onwards (Serological Phase) | Day 3–5 Onwards | Day 1–7 (Viremic Phase) |
| IgG/IgM Differentiation | Yes – Simultaneous Qualitative Detection | Yes – Separate Wells Required | No – Detects Viral RNA Only |
| Sample Volume | 2 mL Serum (1 SST); 1 mL Minimum | 2–3 mL Serum | 2 mL Whole Blood or Serum |
Physician Insight & Clinical Safety Protocol
Dr. PRABHAKAR REDDY — Consultant Physician, DHA License: 61713011
"As a clinician practicing in the UAE, I have managed hundreds of dengue cases where timely serological stratification via IgG and IgM ICT testing directly influenced management decisions. Please understand that a positive IgM result with concurrent thrombocytopenia and rising hematocrit demands immediate clinical correlation — this test guides but never replaces comprehensive bedside assessment. I urge every patient to complete the recommended follow-up, including serial complete blood counts, and to never discontinue prescribed medication without consulting their treating physician."
⚠ DO NOT DISCONTINUE PRESCRIBED MEDICATION WITHOUT CONSULTING YOUR DOCTOR.
This serological test is a diagnostic aid. Altering or stopping any prescribed therapy — including antipyretics, analgesics, or fluid management protocols — based solely on these results without physician consultation may lead to serious clinical deterioration, particularly in severe dengue with plasma leakage.
⛔ Patient Safety: Exclusion Criteria & Emergency Red Flags
Exclusion Criteria for Home Collection
- Known immunoglobulin deficiency disorders (CVID, selective IgM deficiency) that invalidate serological interpretation
- Current therapeutic anticoagulation at supra-therapeutic levels with active bleeding — requires hospital-based phlebotomy
- Severe thrombocytopenia (platelets < 20,000/µL) with spontaneous mucosal bleeding
- Hemodynamic instability: systolic BP < 90 mmHg, tachycardia > 120 bpm at rest
- Altered mental status or Glasgow Coma Scale < 15
🚨 Emergency Red Flags — Seek Immediate Hospital Care
- Severe, persistent abdominal pain or tenderness
- Persistent vomiting (≥ 3 episodes in 1 hour or ≥ 5 episodes in 6 hours)
- Mucosal bleeding: gingival, epistaxis, melena, hematemesis, menorrhagia
- Lethargy, restlessness, or acute confusion
- Clinical fluid accumulation: pleural effusion, ascites, periorbital edema
- Rapid, labored breathing (respiratory rate > 30/min) or SpO₂ < 92%
- Hematocrit rise ≥ 20% from baseline with rapid platelet decline
If any red flag symptom is present, proceed directly to the nearest DHA-licensed emergency department. Do not wait for serological test results. Dengue with warning signs can progress to severe dengue within 24–48 hours.
Patient FAQ & Clinical Guidance
Q1: What exactly does the Dengue Fever IgG & IgM ICT Test detect, and why are both antibodies measured together?
This rapid immunochromatographic cassette simultaneously detects IgM antibodies indicating acute or recent primary dengue infection and IgG antibodies signaling past exposure, secondary infection, or convalescent-phase immunity from a single 2 mL serum sample. Measuring both immunoglobulins together enables clinicians to distinguish primary dengue (IgM-positive, IgG-negative) from secondary dengue (both IgM and IgG positive), which carries a significantly higher risk of progression to severe dengue with plasma leakage and hemorrhagic manifestations. This differentiation is clinically critical because secondary dengue warrants closer monitoring of hematocrit, platelet count, and hemodynamic status.
Q2: When is the optimal time to get tested for dengue antibodies after fever onset?
The optimal testing window for dengue IgM seroconversion is between day 3 and day 7 after fever onset, when IgM antibodies become reliably detectable by immunochromatographic assay in over 90% of primary dengue cases. Testing too early (day 1–2) may yield a false-negative IgM result because the adaptive humoral immune response has not yet produced sufficient antibody titers. If dengue is strongly suspected within the first 48 hours of fever, your physician may recommend paired testing — an NS1 antigen or RT-PCR test for the viremic phase, followed by this IgG & IgM ICT panel on day 4–5 for serological confirmation.
Q3: What does a positive IgG with negative IgM result actually mean for my health status?
A positive IgG with negative IgM pattern on this ICT panel indicates past dengue virus exposure with immunological memory, suggesting you have recovered from a prior dengue infection and are no longer in the acute phase of illness. This serological profile is commonly seen in individuals who reside in or have traveled to dengue-endemic regions, including parts of Asia, Africa, and Latin America. Importantly, this past-exposure pattern means you possess serotype-specific immunity to the infecting dengue serotype but remain susceptible to the other three serotypes — and any subsequent infection with a different serotype carries an elevated risk of antibody-dependent enhancement (ADE) and severe dengue.
ظهور نتيجة IgG إيجابية مع IgM سلبية يعني وجود مناعة مكتسبة من إصابة سابقة بحمى الضنك دون وجود عدوى حادة نشطة حالياً، ولكن يبقى المريض عرضة للإصابة بالأنماط المصلية الأخرى مع خطر متزايد للإصابة بحمى الضنك الشديدة. يُنصح المرضى الذين يحملون هذا النمط المصلي بتجنب لدغات البعوض في المناطق الموبوءة وإبلاغ الطبيب بتاريخهم المناعي عند ظهور أعراض حموية جديدة.
Pre- Information & Sample Logistics
Preparation Required: No special preparation — fasting is not required. Hydration is recommended to facilitate venous access.
Specimen Collection: 2 mL (minimum 1 mL) serum collected in a single Serum Separator Tube (SST) via standard venipuncture. The gold-top SST allows on-site clot formation and centrifugation.
Transport & Stability: Specimen must be shipped refrigerated (2–8°C) within 4 hours of collection, or frozen (-20°C) if transport exceeds 24 hours. Our ISO-certified cold-chain logistics fleet maintains continuous temperature monitoring throughout transit.
Interfering Substances (Avoid): Hemolyzed, lipemic, or icteric specimens may produce invalid results. Recent intravenous immunoglobulin (IVIG) therapy or flavivirus vaccination (Yellow Fever, Japanese Encephalitis) within 4 weeks may cause serological cross-reactivity. Inform the phlebotomist of any recent immunizations.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians